|Articles|March 1, 2012

BioPharm International

  • BioPharm International-03-01-2012
  • Volume 25
  • Issue 3

BioPharm International, March 2012 Issue (PDF)

Scale-Up of Human Stem Cells
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

almost 14 years ago

Scale-up of Human Mesenchymal Stem Cells on Microcarriers in Suspension in a Single-use Bioreactor

almost 14 years ago

Recombinant Albumin Facilitates Formulation Design of Stable Drug Products

almost 14 years ago

Biosimilar Developers Face a Reference-Product Dilemma

almost 14 years ago

Communications Advances Present Challenges to Manufacturers

almost 14 years ago

The Drive for Best Practice in Biopharmaceutical Manufacturing

almost 14 years ago

CMOs Face a Kodak Moment

almost 14 years ago

FDA Guides the Way to Biosimilars in the US

almost 14 years ago

Assessing Filling Technologies For Contamination Risk

almost 14 years ago

Putting Risk-Based Decision-Making Where It Belongs

almost 14 years ago

A 25-Year Retrospective on the Public's Perception of the Biopharmaceutical and Biotech Industry

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!